Name Title

Stephen L. Klincewicz VP and Head, Global Drug Safety, (global head of drug safety for Bayer Consumer Care)

Roy Brisendine Pharmacovigilance / PVAs / REMS/SDEAs

Rosina Dixon Senior Director, Pharmacovigilance
Robin Geller, PhD Director, Risk Management and Safety Writing; Global Pharmacovigilance
Ravi Deshpande Vice President, Post-Marketing Risk and Registry Solutions
Monica Rusu Director, Pharmacovigilance EE&LA; Coordinator Regional PV Management Global Pharmacovigila
Mary Alicino Director, Drug Safety Public Health
Kenneth Kostenbader VP and Head, US Drug Safety
Gary Appio, PharmD Head - US Safety Risk Management; US Medical and Drug Regulatory Affairs
Eric Cantor, MD Head, Medical Affairs & Global Safety & Pharmacovigilance
Douglas Roepke, MD Medical Advisor, Global Patient Safety
Ashraf Youssef MD, PhD, DABT, MBA Associate Medical Director, Phamracovigilance
Anuradha Jasti Senior Director, Global Operations Safety & Pharmacovigilance
Ann Strauss MD Global Pharmacovigilance and Risk Management
Anders Lindholm, MD, PhD VP, Global Pharmacovigilance & Risk Management
Mathew Lee Senior Manager, Risk Management
Ann Strauss MD Global Pharmacovigilance and Risk Management
Mr Michael Ibara Head of Pharmacovigilance Information Management
Senior Vice President, Worldwide
John Balian Safety & Regulatory Operations
Dr Carmen Bozic Vice President and Global Head of Drug, Safety and Risk Management
Company Contact NumberEmail Address
Bayer Healthcare 1.732.524.0400 sklincew@its.jnj.com

Teva Branded Pharmaceuticals USA

Sanofi-Aventis
Baxter Healthcare Corporation 1.847.948.3151 robin_geller@baxter.com
Mckesson Specialty Care Solutions 1.415.983.8300 ravi.deshpande@mckesson.com
Abbott Products GmbH
Gilead Sciences
Actelion Pharmaceuticals
Novartis Pharmaceuticals Corp
GE Healthcare, Medical Diagnostics
Eli Lilly & Co
Takeda Global Research and Development
1.224.554.6359 ayoussef@tgrd.com
National Institutes of Health
Shire
Shire
Lundbeck
Shire
Pfizer Inc. 1.212.733.6794 michael.ibara@pfizer.com

Pfizer inc
Biogen Idec 1.617.679.2068 carmen.bozic@biogenidec.com
Comments

Also attended April Worl Drug Safety 2011 in Boston. Teva Branded
Pharmaceutical Products R&D, Inc.
Venue
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011

Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011

Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011
Pharmacovigilance and Adverse Event Reporting Forum May 12 -13, 2011